For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Publishing research using ab154131? Please let us know so that we can cite the reference in this datasheet.
ab154131 has been referenced in 5 publications.
- Reyes-Soffer G et al. Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans. Circulation 135:352-362 (2017).
- Millar JS et al. Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E. J Lipid Res 58:1214-1220 (2017).
- Luo M et al. ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity. Sci Rep 7:2312 (2017).
- Lin Q et al. Decreased expression of the APOA1-APOC3-APOA4 gene cluster is associated with risk of Alzheimer's disease. Drug Des Devel Ther 9:5421-31 (2015).
- Xiong X et al. The association of HDL-apoCIII with coronary heart disease and the effect of statin treatment on it. Lipids Health Dis 14:127 (2015).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"